Exportar registro bibliográfico


Metrics:

Capecitabine/oxaliplatin (XELOX) versus XELOX plus bevacizumab (XELOX + bev) cost-effectiveness for metastatic colorectal cancer (mCRC) in first line treatment: a Brazilian public hospital analysis (2016)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020